Evidence map›Paper›PMID 34842136›Full record

ArticleeLife2021

Membrane estrogen receptor alpha (ERα) participates in flow-mediated dilation in a ligand-independent manner.

Julie Favre, Emilie Vessieres, Anne-Laure Guihot, Coralyne Proux, Linda Grimaud, Jordan Rivron, Manuela Cl Garcia, Léa Réthoré, Rana Zahreddine, Morgane Davezac and 10 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Sex, Endothelial Cell Functions, and Peripheral Artery Disease.International journal of molecular sciences · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 2 countries.

Julie Favre *Angers University, MITOVASC, CNRS UMR 6015, INSERM U1083, Angers, France.
Emilie Vessieres *Angers University, MITOVASC, CNRS UMR 6015, INSERM U1083, Angers, France.
Anne-Laure GuihotAngers University, MITOVASC, CNRS UMR 6015, INSERM U1083, Angers, France.
Coralyne ProuxAngers University, MITOVASC, CNRS UMR 6015, INSERM U1083, Angers, France.
Linda GrimaudAngers University, MITOVASC, CNRS UMR 6015, INSERM U1083, Angers, France.
Jordan RivronAngers University, MITOVASC, CNRS UMR 6015, INSERM U1083, Angers, France.
Manuela Cl GarciaAngers University, MITOVASC, CNRS UMR 6015, INSERM U1083, Angers, France.
Léa RéthoréAngers University, MITOVASC, CNRS UMR 6015, INSERM U1083, Angers, France.
Rana ZahreddineINSERM U1297, Paul Sabatier University (Toulouse III) , University Hospital (UHC) of Toulouse, Toulouse, France.
Morgane DavezacINSERM U1297, Paul Sabatier University (Toulouse III) , University Hospital (UHC) of Toulouse, Toulouse, France.
Chanaelle FébrissyINSERM U1297, Paul Sabatier University (Toulouse III) , University Hospital (UHC) of Toulouse, Toulouse, France.
Marine AdlanmeriniINSERM U1297, Paul Sabatier University (Toulouse III) , University Hospital (UHC) of Toulouse, Toulouse, France.
Laurent LoufraniAngers University, MITOVASC, CNRS UMR 6015, INSERM U1083, Angers, France.ORCID 0000-0003-3397-2335
Vincent ProcaccioAngers University, MITOVASC, CNRS UMR 6015, INSERM U1083, Angers, France.
Jean-Michel FoidartGroupe Interdisciplinaire de Génoprotéomique Appliquée, Université de Liège, Liège, Belgium.
Gilles FlouriotINSERM U1085, IRSET (Institut de Recherche en Santé, Environnement et Travail), University of Rennes, Rennes, France.
Françoise LenfantINSERM U1297, Paul Sabatier University (Toulouse III) , University Hospital (UHC) of Toulouse, Toulouse, France.
Coralie FontaineINSERM U1297, Paul Sabatier University (Toulouse III) , University Hospital (UHC) of Toulouse, Toulouse, France.
Jean-François ArnalINSERM U1297, Paul Sabatier University (Toulouse III) , University Hospital (UHC) of Toulouse, Toulouse, France.
Daniel HenrionAngers University, MITOVASC, CNRS UMR 6015, INSERM U1083, Angers, France.ORCID 0000-0003-1094-0285
Inserm · FRUniversité Toulouse III - Paul Sabatier · FRUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Estrogen receptor alpha (ERα) activation by estrogens prevents atheroma through its nuclear action, whereas plasma membrane-located ERα accelerates endothelial healing. The genetic deficiency of ERα was associated with a reduction in flow-mediated dilation (FMD) in one man. Here, we evaluated ex vivo the role of ERα on FMD of resistance arteries. FMD, but not agonist (acetylcholine, insulin)-mediated dilation, was reduced in male and female mice lacking ERα (

Indexed as

Blood CirculationAnimalsEstrogen Receptor alphaFemaleHydrogen PeroxideLigandsMaleMiceEsr1 protein, mouseEstrogen Receptor alphaHydrogen PeroxideLigandsblood flowcell biologyendotheliumestrogen receptorsmouseresistance arteriesshear stress

Identifiers

PMID34842136
PMCPMC8676342
OpenAlexW3215154110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.